Longitudinal decline of pulmonary function in cough variant asthma and atopic cough

M. Fujimura, M. Nishitsuji, Y. Nishizawa, T. Kita (Ishikawa, Kanazawa, Japan)

Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Session: Asthma: Inflammation, hyperreactivity, treatment side effects
Session type: Thematic Poster Session
Number: 429
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Cough variant asthma (CVA) and atopic cough (AC) are different clinical manifestations of eosinophilic airway inflammation presenting with isolated chronic non-productive cough. Longitudinal change of pulmonary function in CVA and AC is unknown. Thus, we examined the longitudinal change of FEV1 in patients with CVA and AC.
Twenty patients with CVA, 14 patients with AC and 271 asymptomatic healthy subjects were prospectively examined. Thirteen patients with CVA were taking long-term inhaled corticosteroid therapy (ICS) (beclomethasone dipropionate 615 ±] 58 μg/day) and other 7 patients were not. Spirometry was taken at first visit, after cough was almost completely relieved on therapy and at least once every year for 5 or more years afterwards.
Slope of longitudinal change in FEV1 was -0.029 ±] 0.007, –0.021 ±] 0.022 and -0.028 ±] 0.002 l/year in CVA patients, AC patients and asymptomatic subjects, respectively, and these values were not significantly different. In patients with CVA, the slope in patients without ICS was –0.032 ±] 0.007 l/year, which was not different from that in patients with ICS (-0.027 ±] 0.010 l/year).
The pulmonary function decline is not greater in CVA than AC and normal population, and long-term ICS has no benefit for the decline in CVA.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fujimura, M. Nishitsuji, Y. Nishizawa, T. Kita (Ishikawa, Kanazawa, Japan). Longitudinal decline of pulmonary function in cough variant asthma and atopic cough. Eur Respir J 2002; 20: Suppl. 38, 429

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Maximal airway response in patients with asthma and cough variant asthma
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007


Predictors for asthma onset from cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002

Airway responsiveness in patients with cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 50s
Year: 2002

Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017
Year: 2017



Importance of atopic cough and cough variant asthma as causes of chronic cough in Hokuriku area of Japan
Source: Eur Respir J 2003; 22: Suppl. 45, 373s
Year: 2003

Differences and similarities between patients with cough variant asthma and cough predominant asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019

Snoring is related to recurrent wheezing, rhinitis and dyspnea but not to type-1 allergy or bronchial hyperresponsiveness
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004

Cough variant asthma may be a incipience of bronchial asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012

Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003

Bronchial hyperreactivity in children with cough variant of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002

Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004

Epinastine improves cough in eosinophilic bronchitis (atopic cough)
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Localization of hyaluronan in airways of patients with cough variant asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010


Role of respiratory infection in exacerbations of atopic asthma
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Bronchial hyperresponsiveness and perception of dyspnea in children with allergic rhinitis and bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 441s
Year: 2004

Treatment of bronchial asthma and wheezing disorders: chronic
Source: ERS Skills Course 2016
Year: 2016

Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017